Prognostic significance of fascin expression in stage I non-small cell lung cancer

Tuberculosis and Respiratory Diseases

Volumn 65, Issue 2, 2008, Pages 105-109

  Roh, Mee Sook ^a   Um, Su Jung ^a   Choi, Youngmin ^a   Kim, Ki Nam ^a   Pil, Jo Choi ^a   Lee, Soo Keol ^a   Son, Choonhee ^a   Yang, Dookyung ^a  

^a Dong A University College of Medicine   (South Korea)

Author keywords

Fascin; Lung cancer; Prognosis

Indexed keywords

BIOLOGICAL MARKER; FASCIN; PARAFFIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STAINING; TISSUE SECTION; TUMOR CELL; TUMOR RECURRENCE;

EID: 51449091412     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2008.65.2.105     Document Type: Article

References (16)

1. Minna JD. Chapter 75. Neoplasms of the lung. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison's principles of internal medicine. 16th ed. New York: McGraw-Hill Co, Inc.; 2005. p. 506-15.
2. Hilsenbeck SG, Raub WA Jr, Sridhar KS. Prognostic factors in lung cancer based on multivariate analysis. Am J Clin Oncol 1993;16:301-9.
3. Mountain CF. New prognostic factors in lung cancer, biologic prophets of cancer cell aggression. Chest 1995;108:246-54.
4. Zhu CQ, Shih W, Ling CH, Tsao MS. Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation. J Clin Pathol 2006;59:790-800.
5. Niklinski J, Niklinska W, Laudanski J, Chyczewska E, Chyczewski L. Prognostic molecular markers in non-small cell lung cancer. Lung Cancer 2001;34:S53-8.
6. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006;12:895-904.
7. Carragher NO, Frame MC. Focal adhesion and actin dynamics: a place where kinases and proteases meet to promote invasion. Trends Cell Biol 2004;14:241-9.
8. Kureishy N, Sapountzi V, Prag S, Anikumar N, Adams JC. Fascins, and their roles in cell structure and function. Bioessays 2002;24:350-61.
9. Yamashiro S, Yamakita Y, Ono S, Matsumura F. Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. Mol Biol Cell 1998;9:993-1006.
10. Hashimoto Y, Shimada Y, Kawamura J, Yamasaki S, Imamura M. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 2004;67:262-70.
11. Yoder BJ, Tso E, Skacel M, Pettay J, Tarr S, Budd T, et al. The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. Clin Cancer Res 2005;11:186-92.
12. Hashimoto Y, Skacel M, Adams JC. Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J Biochem Cell Biol 2005;537:1787-804.
13. Choi PJ, Yang DK, Son CH, Lee KE, Lee JI, Roh MS. Fascin immunoreactivity for preoperatively predicting lymph node metastases in peripheral adenocarcinoma of the lung 3 cm or less in diameter. Eur J Cardiothorac Surg 2006;30:538-42.
14. Pelosi G, Pastorino U, Pasini F, Maissoneuve P, Fraggetta F, Iannucci A, et al. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer 2003;88:537-47.
15. Bryan J, Edwards R, Matsudaira P, Otto J, Wulfkuhle J. Fascin, an echinoid actin-bundling protein, is a homolog of Drosophila singed gene product. Proc Natl Acad Sci U S A 1993;90:9115-9.
16. Hu W, McCrea PD, Deavers M, Kavanagh JJ, Kudelka AP, Verschraegen CF. Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors. Clin Exp Metastasis 2000;18:83-8.